Peptide-oligourea foldamer compounds and methods of their use
Langue
EN
Brevet
Ce document a été publié dans
2019
Résumé en anglais
The present description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various ...Lire la suite >
The present description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.< Réduire
N° de brevet
EP 3 466 979 A1Unités de recherche